Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system
Neurochemistry International · 2023-12 · 171 · 105633
DOI: 10.1016/j.neuint.2023.105633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2023-12. Verfasst von Xian Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Elect…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Department of Education of Liaoning Province, Taishan Industry Leading Talents, National Natural Science Foundation of China.
Abstract (Originalsprache)
The number of patients with Alzheimer's disease is increasing year by year, but only a few medications are available. We found that OAB-14, a new small molecule, can improve cognitive deficits in various mouse AD models. The structure and mechanism of OAB-14 are distinct from anti-AD medications that have been unsuccessful in recent clinical trials. OAB-14 can effectively reduce the accumulation of Aβ in the brain, but has no inhibitory effect on Aβ production enzymes. Reportedly, Aβ can be drained into the systemic circulation to be metabolized through the glymphatic system and meningeal lymphatic vessels. Our research has shown that OAB-14 is capable of enhancing the glymphatic system function by promoting the influx and efflux of the CSF tracers to the brain and deep cervical lymph nodes, respectively. After blocking the central lymphatic drainage, the effect of OAB-14 in improving cognitive impairments disappeared. Furthermore, OAB-14 may up-regulate AQP4 expression by acting on PPARγ-P2X7r-AQP4 pathway and protect the polarity of AQP4 by upregulating the expression of SNTA1, Agrin, and Abca1, which are closely associated with the proper functioning of the glymphatic system. In summary, OAB-14 can promote the clearance of brain Aβ through the glymphatic system and improve cognitive impairment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: 424258422@qq.com.
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: ca…
- Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: 2008.zc.love@163.com.
- Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: yanglucy@126.com.
- Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: 15552371335@163.com.
- Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: j17562718979@163.com.
Förderung
- Department of Education of Liaoning Province
- Taishan Industry Leading Talents
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Cao, R., Zhu, C., Yang, L., Zheng, N., Ji, W., Liu, P., Chi, T., Ji, X., Zheng, Z., Chen, G., & Zou, L. (2023). Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system. Neurochemistry International, 171, 105633. https://doi.org/10.1016/j.neuint.2023.105633
Vancouver
Zhang X, Cao R, Zhu C, Yang L, Zheng N, Ji W, et al. Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system. Neurochemistry International. 2023;171:105633. doi:10.1016/j.neuint.2023.105633
BibTeX
@article{Zhang2023,
author = {Zhang, Xian and Cao, Ruolin and Zhu, Chao and Yang, Luxi and Zheng, Na and Ji, Wenshuang and Liu, Peng and Chi, Tianyan and Ji, Xuefei and Zheng, Zhonghui and Chen, Guoliang and Zou, Libo},
title = {Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system},
journal = {Neurochemistry International},
year = {2023},
volume = {171},
pages = {105633},
doi = {10.1016/j.neuint.2023.105633}
}
EUVIMED